Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies ; volume:29 ; number:1 ; day:28 ; month:12 ; year:2010 ; pages:1-9 ; date:12.2010
Journal of experimental & clinical cancer research ; 29, Heft 1 (28.12.2010), 1-9, 12.2010
- Urheber
-
Ben Jemaa, Awatef
Bouraoui, Yosra
Sallami, Sataa
Banasr, Ahmed
Rais, Nawfel Ben
Ouertani, Latifa
Nouira, Yassin
Horchani, Ali
Oueslati, Ridha
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-29-171
- URN
-
urn:nbn:de:101:1-2021081420473531538805
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ben Jemaa, Awatef
- Bouraoui, Yosra
- Sallami, Sataa
- Banasr, Ahmed
- Rais, Nawfel Ben
- Ouertani, Latifa
- Nouira, Yassin
- Horchani, Ali
- Oueslati, Ridha
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen